Top Healthcare companies in Italy by Net Cash Used For Investing Activities
Italy
# |
Name |
Net Cash Used For Investing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 3.58 M
|
Dec. 31, 2023 | USD 10.86 | 4.76% |
|
Italy |
|
| 2 |
USD 175.50 K
|
Dec. 31, 2023 | USD 19.14 | -0.29% |
|
Italy |
|
| 3 |
USD -925.86 K
|
Dec. 31, 2023 | USD 1.99 | -0.79% |
|
Italy |
|
| 4 |
USD -16.23 M
|
Dec. 31, 2023 | USD 53.58 | -1.47% |
|
Italy |
|
| 5 |
USD -16.44 M
|
Dec. 31, 2023 | USD 3.52 | -12.00% |
|
Italy |
|
| 6 |
USD -32.12 M
|
Dec. 31, 2023 | USD 107.00 | 0.25% |
|
Italy |
|
| 7 |
USD -253.81 M
|
Dec. 31, 2023 | USD 9.97 | 0.35% |
|
Italy |
|
| 8 |
USD -419.00 M
|
Dec. 31, 2023 | USD 61.85 | 0.84% |
|
Italy |
|
| 9 |
USD -464.92 M
|
Dec. 31, 2023 | USD 22.41 | 2.19% |
|
Italy |
Frequently Asked Questions
-
Which Healthcare company in Italy has the highest Net Cash Used For Investing Activities ?
The Healthcare company in Italy with the highest Net Cash Used For Investing Activities is Newron Pharmaceuticals S.p.A. (XETRA: NP5.DE) at USD 3.58 M.
-
Which Healthcare company in Italy has the lowest Net Cash Used For Investing Activities ?
The Healthcare company in Italy with the lowest Net Cash Used For Investing Activities is Stevanato Group S.p.A. (NYSE: STVN) at USD -464.92 M.
-
What are the top 10 Healthcare companies in Italy by Net Cash Used For Investing Activities ?
The top 10 Healthcare companies in Italy by Net Cash Used For Investing Activities are Newron Pharmaceuticals S.p.A., Philogen S.p.A., Arterra Bioscience, Pharmanutra S.p.A., Genenta Science S.p.A., DiaSorin S.p.A., GPI S.p.A., Recordati Industria Chimica e Farmaceutica S.p.A. and Stevanato Group S.p.A..
-
What are the bottom 10 Healthcare companies in Italy by Net Cash Used For Investing Activities ?
The bottom 10 Healthcare companies in Italy by Net Cash Used For Investing Activities are Stevanato Group S.p.A., Recordati Industria Chimica e Farmaceutica S.p.A., GPI S.p.A., DiaSorin S.p.A., Genenta Science S.p.A., Pharmanutra S.p.A., Arterra Bioscience, Philogen S.p.A. and Newron Pharmaceuticals S.p.A..
